Entering text into the input field will update the search result below

La Jolla Pharmaceutical GAAP EPS of $0.00 misses by $0.01, revenue of $10.43M misses by $2.67M

May 16, 2022 4:41 PM ETInnoviva, Inc. (INVA) StockBy: Niloofer Shaikh, SA News Editor
  • La Jolla Pharmaceutical press release (NASDAQ:LJPC): Q1 GAAP EPS of $0.00 misses by $0.01.
  • Revenue of $10.43M (-69.4% Y/Y) misses by $2.67M.
  • “We are pleased to report that La Jolla continues to grow net product sales and generate positive operating cash flow,” said Larry Edwards, President and Chief Executive Officer of La Jolla. “La Jolla’s focus remains on growing its GIAPREZA and XERAVA franchises while increasing operating cash flow.”

Recommended For You

More Trending News

About INVA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
INVA--
Innoviva, Inc.